Concepedia

Karen N. Price

KN

Statistics

Publications

83

Citations

15.2K

H-Index

56

Active since

1988

Affiliations

European Institute of Oncology(Current)

International Breast Cancer Study Group

Dana-Farber Cancer Institute

Frontier Science & Technology Research Foundation

The University of Sydney

Karen N. Price is an author at European Institute of Oncology specializing in breast cancer, oncology, and medicine.

Top concepts

Publications per year

1988–2020

83

Publications

83

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

Viviana Galimberti, Bernard F. Cole, Stefano Zurrida et al. · The Lancet Oncology · 2013 · 1.2K citations · Full text

, , +5

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

Alan S. Coates, Aparna Keshaviah, Beat Thürlimann et al. · Journal of Clinical Oncology · 2007 · 897 citations

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

B.A. Gusterson, RD Gelber, Aron Goldhirsch et al. · Journal of Clinical Oncology · 1992 · 842 citations

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

Olivia Pagani, Meredith M. Regan, Barbara Walley et al. · New England Journal of Medicine · 2014 · 738 citations · Full text

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

Prudence A. Francis, Meredith M. Regan, Gini F. Fleming et al. · New England Journal of Medicine · 2014 · 720 citations · Full text

Rows per page

1–5 of 83